Social Taboos, Lack of Awareness May Prevent Diagnosis and Treatment of IBS

IFFGD Breaks Down Taboos for IBS Awareness Month

It may come as a surprise to many, since it’s often regarded as a trivial condition, but irritable bowel syndrome (IBS) is one of the most prevalent and burdensome chronic conditions reported by
patients. An estimated 30 to 45 million people in the United States – 10 to 15 percent of the population – are affected by IBS. It’s been cited as the second leading cause of work absenteeism
(second only to the common cold) and was found to cause those affected to restrict their personal and professional activities an average of 20 percent of the year (73 days). But, despite the high prevalence and well-documented burden, much about IBS remains unknown, and myths and misconceptions about the disorder are common among patients as well as the general public.

“Despite being very common, many with IBS are reluctant to openly talk about their symptoms or seek medical care,” said Ceciel T. Rooker, President of the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a registered nonprofit organization dedicated to improving the lives of people with IBS and other chronic gastrointestinal (GI) disorders. “They may feel uncomfortable discussing their symptoms, even with their doctor, because of social taboos surrounding bowel symptoms.”

April is IBS Awareness Month. First designated by IFFGD in 1997 to bring awareness to this often misunderstood and stigmatized condition, IBS Awareness Month is now recognized nationwide.
During this time and throughout the year, IFFGD is committed to raising awareness and breaking down taboos which may keep affected individuals from obtaining a diagnosis and receiving appropriate care.

“It’s important to encourage open and honest conversation about IBS symptoms and quality of life issues and remove barriers that may prevent those affected from enjoying a normal, active life,” Rooker concluded.